The Evolving Role of Biomarkers in Personalized Lung Cancer Therapy

Publisher： Karger

E-ISSN： 1423-0356|93|1|1-14

ISSN： 0025-7931

Source： Respiration, Vol.93, Iss.1, 2016-11, pp. : 1-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Personalized Therapy of Lung Cancer

By  

Oncology Research and Treatment, Vol. 35, Iss. 1, 2012-01 ,pp. : 14-19

Karger

Access to resources Recommend Favorite

Advances in personalized therapy for lung cancer

By Kim Eric S   Pandya Kishan J  

Expert Opinion on Medical Diagnostics, Vol. 7, Iss. 5, 2013-09 ,pp. : 475-485

Informa Healthcare

Access to resources Recommend Favorite

Evolving role of serum biomarkers in the management of ovarian cancer

By Gadducci Angiolo   Cosio Stefania   Zanca Giulia   Genazzani Andrea Riccardo  

Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. : 141-158

Future Medicine

Access to resources Recommend Favorite

Evolving treatment paradigms in lung cancer: role of immuno‐oncology

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. S1, 2015-04 ,pp. : 1-1

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacogenomic biomarkers for personalized cancer treatment

By  

JOURNAL OF INTERNAL MEDICINE, Vol. 277, Iss. 2, 2015-02 ,pp. : 201-217

John Wiley & Sons Inc

Access to resources Recommend Favorite